Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (UNAUDITED)

v3.8.0.1
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' DEFICIT (UNAUDITED) - 9 months ended Sep. 30, 2017 - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated (Deficit)
Total
Beginning Balance, Shares at Dec. 31, 2016 73,509,663      
Beginning Balance, Amount at Dec. 31, 2016 $ 73,510 $ 49,838,469 $ (54,883,223) $ (4,971,244)
Stock issued upon debt conversion, Shares 51,236      
Stock issued upon debt conversion, Amount $ 51 25,567 25,618
Stock issued upon cashless warrant exercise, Shares 630,214      
Stock issued upon cashless warrant exercise, Amount $ 630 230,347 230,977
Stock issued per settlement agreement, Shares 130,000      
Stock issued per settlement agreement, Amount $ 130 60,970 61,100
Stock issued for the acquisition of patents rights, Shares 925,000      
Stock issued for the acquisition of patents rights, Amount $ 925 517,075 518,000
Issuance of stock options 1,275,773 1,275,773
Stock issued to non-employees, Shares 1,000,000      
Stock issued to non-employees, Amount $ 1,000 160,875 161,875
Net loss 95,410 95,410
Ending Balance, Shares at Sep. 30, 2017 76,246,113      
Ending Balance, Amount at Sep. 30, 2017 $ 76,246 $ 52,109,076 $ (54,787,813) $ (2,602,491)